John Varian Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Varian.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Varian. John Varian is CEO in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and Director in SELLAS Life Sciences Group, Inc. ($GALE) and COO & CFO in ARYx Therapeutics, Inc. ($ARYX) and Director in Versartis, Inc. ($VSAR) and Director in Egalet Corp ($EGLT).
Latest Insider Trading Transactions of John Varian
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARAV, ARYX, SLS, XOMA, EGLT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2020 | SLS | SELLAS Life Scienc ... | Varian John | Director | Option Exercise | A | 1.89 | 6,500 | 12,285 | 6,500 | |
| Mar 18 2019 | SLS | SELLAS Life Scienc ... | Varian John | Director | Option Exercise | A | 1.38 | 25,000 | 34,500 | 25,000 | |
| Feb 04 2019 | EGLT | Egalet Corp | Varian John | Director | Option Exercise | D | 0.40 | 110,000 | 44,000 | 0 | |
| Jul 02 2018 | EGLT | Egalet Corp | Varian John | Director | Option Exercise | A | 0.40 | 110,000 | 44,000 | 110,000 | |
| Jul 02 2018 | EGLT | Egalet Corp | Varian John | Director | Option Exercise | A | 0.40 | 110,000 | 44,000 | 110,000 | |
| Jun 13 2018 | SLS | SELLAS Life Scienc ... | Varian John | Director | Option Exercise | A | 5.23 | 5,500 | 28,765 | 5,500 | |
| Mar 15 2018 | GALE | SELLAS Life Scienc ... | Varian John | Director | Option Exercise | A | 5.24 | 11,000 | 57,640 | 11,000 | |
| Dec 22 2017 | VSAR | Versartis, Inc. | Varian John | Director | Grant | A | 0.00 | 11,200 | 0 | 22,280 | 11.1 K to 22.3 K (+101.08 %) |
| Jun 06 2017 | VSAR | Versartis, Inc. | Varian John | Director | Option Exercise | A | 15.83 | 6,850 | 108,401 | 6,850 | |
| Jun 06 2017 | VSAR | Versartis, Inc. | Varian John | Director | Grant | A | 0.00 | 3,480 | 0 | 11,080 | 7.6 K to 11.1 K (+45.79 %) |
| May 22 2017 | XOMA | XOMA Corp | Varian John | Director | Option Exercise | A | 4.03 | 8,000 | 32,240 | 8,000 | |
| May 18 2017 | XOMA | XOMA Corp | Varian John | Director | Sell | S | 6.24 | 39,540 | 246,919 | 2,344 | 41.9 K to 2.3 K (-94.40 %) |
| Dec 23 2016 | XOMA | XOMA Corp | Varian John | Director | Sell | S | 5.75 | 13,549 | 77,907 | 41,884 | 55.4 K to 41.9 K (-24.44 %) |
| Aug 26 2016 | VSAR | Versartis, Inc. | Varian John | Director | Sell | S | 12.97 | 1,600 | 20,755 | 7,600 | 9.2 K to 7.6 K (-17.39 %) |
| May 20 2016 | VSAR | Versartis, Inc. | Varian John | Director | Option Exercise | A | 8.12 | 14,625 | 118,755 | 14,625 | |
| May 20 2016 | VSAR | Versartis, Inc. | Varian John | Director | Grant | A | 0.00 | 4,625 | 0 | 9,200 | 4.6 K to 9.2 K (+101.09 %) |
| Mar 22 2016 | XOMA | XOMA Corp | Varian John | CEO | Option Exercise | M | 0.00 | 36,907 | 0 | 0 | |
| Mar 22 2016 | XOMA | XOMA Corp | Varian John | CEO | Sell | S | 0.78 | 81,022 | 63,578 | 1,108,673 | 1.2 M to 1.1 M (-6.81 %) |
| Mar 22 2016 | XOMA | XOMA Corp | Varian John | CEO | Buy | M | 0.00 | 36,907 | 0 | 1,189,695 | 1.2 M to 1.2 M (+3.20 %) |
| Feb 29 2016 | XOMA | XOMA Corp | Varian John | CEO | Grant | A | 0.00 | 541,600 | 0 | 1,152,788 | 611.2 K to 1.2 M (+88.61 %) |
| Aug 18 2015 | XOMA | XOMA Corp | Varian John | CEO | Option Exercise | M | 0.00 | 94,573 | 0 | 195,239 | |
| Aug 18 2015 | XOMA | XOMA Corp | Varian John | CEO | Buy | M | 0.00 | 94,573 | 0 | 611,188 | 516.6 K to 611.2 K (+18.31 %) |
| Aug 18 2015 | XOMA | XOMA Corp | Varian John | CEO | Sell | D | 0.83 | 35,799 | 29,838 | 516,615 | 552.4 K to 516.6 K (-6.48 %) |
| Jul 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Option Exercise | M | 1.24 | 10,000 | 12,400 | 70,392 | |
| Jul 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Sell | S | 4.49 | 10,000 | 44,869 | 552,414 | 562.4 K to 552.4 K (-1.78 %) |
| Jul 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Buy | M | 1.24 | 10,000 | 12,400 | 562,414 | 552.4 K to 562.4 K (+1.81 %) |
| Jul 01 2015 | VSAR | Versartis, Inc. | Varian John | Director | Option Exercise | A | 14.73 | 13,100 | 192,963 | 13,100 | |
| Jul 01 2015 | VSAR | Versartis, Inc. | Varian John | Director | Grant | A | 0.00 | 4,575 | 0 | 4,575 | 0 to 4.6 K |
| Jun 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Option Exercise | M | 1.24 | 10,000 | 12,400 | 80,392 | |
| Jun 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Sell | S | 3.64 | 10,000 | 36,362 | 552,414 | 562.4 K to 552.4 K (-1.78 %) |
| Jun 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Buy | M | 1.24 | 10,000 | 12,400 | 562,414 | 552.4 K to 562.4 K (+1.81 %) |
| May 19 2015 | XOMA | XOMA Corp | Varian John | CEO | Option Exercise | M | 1.24 | 10,000 | 12,400 | 90,392 | |
| May 19 2015 | XOMA | XOMA Corp | Varian John | CEO | Sell | S | 3.34 | 10,000 | 33,400 | 552,414 | 562.4 K to 552.4 K (-1.78 %) |
| May 19 2015 | XOMA | XOMA Corp | Varian John | CEO | Buy | M | 1.24 | 10,000 | 12,400 | 562,414 | 552.4 K to 562.4 K (+1.81 %) |
| Apr 15 2015 | XOMA | XOMA Corp | Varian John | CEO | Option Exercise | M | 1.24 | 10,000 | 12,400 | 100,392 | |
| Apr 15 2015 | XOMA | XOMA Corp | Varian John | CEO | Sell | S | 3.86 | 10,000 | 38,606 | 552,414 | 562.4 K to 552.4 K (-1.78 %) |
| Apr 15 2015 | XOMA | XOMA Corp | Varian John | CEO | Buy | M | 1.24 | 10,000 | 12,400 | 562,414 | 552.4 K to 562.4 K (+1.81 %) |
| Mar 20 2015 | XOMA | XOMA Corp | Varian John | CEO | Option Exercise | M | 0.00 | 36,907 | 0 | 36,907 | |
| Mar 20 2015 | XOMA | XOMA Corp | Varian John | CEO | Sell | D | 4.01 | 23,461 | 94,090 | 552,414 | 575.9 K to 552.4 K (-4.07 %) |
| Mar 20 2015 | XOMA | XOMA Corp | Varian John | CEO | Sell | D | 4.01 | 21,416 | 85,889 | 575,875 | 597.3 K to 575.9 K (-3.59 %) |
| Mar 20 2015 | XOMA | XOMA Corp | Varian John | CEO | Buy | M | 0.00 | 36,907 | 0 | 597,291 | 560.4 K to 597.3 K (+6.59 %) |
| Mar 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Option Exercise | M | 1.24 | 10,000 | 12,400 | 110,392 | |
| Mar 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Sell | S | 3.72 | 10,000 | 37,223 | 560,384 | 570.4 K to 560.4 K (-1.75 %) |
| Mar 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Buy | M | 1.24 | 10,000 | 12,400 | 570,384 | 560.4 K to 570.4 K (+1.78 %) |
| Mar 02 2015 | XOMA | XOMA Corp | Varian John | CEO | Option Exercise | A | 3.83 | 266,800 | 1,021,844 | 266,800 | |
| Mar 02 2015 | XOMA | XOMA Corp | Varian John | CEO | Grant | A | 0.00 | 193,200 | 0 | 560,384 | 367.2 K to 560.4 K (+52.62 %) |
| Mar 01 2010 | ARYX | ARYx Therapeutics, ... | Varian John | COO & CFO | Option Exercise | A | 0.00 | 160,000 | 0 | 160,000 | |
| Feb 20 2009 | ARYX | ARYx Therapeutics, ... | Varian John | COO & CFO | Option Exercise | A | 2.70 | 100,000 | 270,000 | 100,000 | |
| Feb 07 2008 | ARYX | ARYx Therapeutics, ... | Varian John | COO & CFO | Option Exercise | A | 7.55 | 44,000 | 332,200 | 44,000 |
Page: 1